The B.A.'s Sir Walter Bodmer On Science in Britain

Q:Since Prime Minister Thatcher came to power in 1979, her three governments have changed the agenda for political debate in Britain. Has Conservative rule also altered the agenda for science policy? Do you believe that the difficulties now facing U.K. science are simply the outcome of an attempt to save money, or are they the result of a coherent plan? BODMER: Definitely not the latter. Our problems are largely to do with cash and with a monetary policy which says that government expenditure

| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Q:Since Prime Minister Thatcher came to power in 1979, her three governments have changed the agenda for political debate in Britain. Has Conservative rule also altered the agenda for science policy? Do you believe that the difficulties now facing U.K. science are simply the outcome of an attempt to save money, or are they the result of a coherent plan?

BODMER: Definitely not the latter. Our problems are largely to do with cash and with a monetary policy which says that government expenditure should go down and that people ought to be more self-sufficient, and which has almost become a religion. This has driven a lot of major changes, some of which—such as the forging of closer links between the universities and industry— have been for the better. But while some campuses, such as Salford, have thrived in that way, others are clearly very concerned at the suggestion that in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies